Article

Validating pathophysiological models of aging using clinical electronic medical records.

Center for Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Journal of Biomedical Informatics (impact factor: 1.79). 11/2009; 43(3):358-64. DOI:10.1016/j.jbi.2009.11.007 pp.358-64
Source: PubMed

ABSTRACT Bioinformatics methods that leverage the vast amounts of clinical data promises to provide insights into underlying molecular mechanisms that help explain human physiological processes. One of these processes is adolescent development. The utility of predictive aging models generated from cross-sectional cohorts and their applicability to separate populations, including the clinical population, has yet to be completely explored. In order to address this, we built regression models predictive of adolescent chronological age from 2001 to 2002 National Health and Nutrition Examination Survey (NHANES) data and validated them against independent 2003-2004 NHANES data and clinical data from an academic tertiary-care pediatric hospital. The results indicate distinct differences between male and female models with both alkaline phosphatase and creatinine as predictive biomarkers for both genders, hematocrit and mean cell volume for males, and total serum globulin for females. We also suggest that the models are generalizable, are clinically relevant, and imply underlying molecular and clinical differences between males and females that may affect prediction accuracy. The integration of both epidemiological and clinical data promises to create more robust models that shed new light on physiological processes.

0 0
 · 
0 Bookmarks
 · 
38 Views
  • Article: Laboratory data in clinical trials: a statistician's perspective.
    [show abstract] [hide abstract]
    ABSTRACT: Even though laboratory data provide the best indicators for systemic toxicities in clinical trials of investigational medications, many applied statisticians lack a basic understanding of the interpretation of such data. Understanding is essential to a statistician's ability to help evaluate a patient's overall safety experience in a trial, the latter being the primary objective for collecting laboratory data in the trial. In this paper, we discuss the purpose of conducting laboratory evaluations as well as some hidden issues concerning the current practice of laboratory data analysis. The issues include the use of reference ranges, the one-parameter-at-a-time approach, and the exploratory nature of safety data analyses.
    Controlled Clinical Trials 04/1998; 19(2):167-77.

Keywords

2002 National Health
 
academic tertiary-care pediatric hospital
 
adolescent chronological age
 
alkaline phosphatase
 
cell volume
 
clinical data
 
clinical data promises
 
clinical differences
 
clinically relevant
 
cross-sectional cohorts
 
female models
 
females
 
molecular mechanisms
 
Nutrition Examination Survey
 
predictive biomarkers
 
regression models predictive
 
robust models
 
shed new light
 
total serum globulin
 
vast amounts